FSA/HSA Eligble
Brain health starts
one layer earlier.
Subtle sensory shifts appear
long before symptoms are obvious
Developed with researchers from Columbia, Johns Hopkins, Harvard, and beyond.
The Science
The brain is only as sharp as its inputs.
Those inputs are the five senses. They decline years before memory does, which is why the earliest signal of brain health starts there.
Medicine has treated the senses as outputs. They are inputs.
Where change begins
Layer 1 · Sensory input
Where the signal enters
Smell, taste, hearing, vision, touch. The information the brain runs on.
SuperSenses measures hereLayer 2 · Neural processing
Where it is carried inward
Integration, activation, network efficiency. The signal moving through the system.
Layer 3 · Cognitive output
Where symptoms surface
Memory, attention, executive function. What conventional tests measure.
Where most tools measureChange often begins at the input. Most assessments only read the output, so by the time they register it, the signal has been shifting for years.
The evidence
Over seven years, hearing aids cut dementia risk by roughly a third. Standard cognitive tests declined about equally in both groups. The change was real before the tests could see it. That interval is the layer sensory measurement follows over time.
Cribb et al., Neurology, 2026."My dream is that we include routine assessments of taste and smell, like we do with regular vision and hearing exams."
"People who have smell and taste issues need care, just like people who have impairments in our other senses, like sight and hearing."
Assessments developed with PhD researchers across Columbia, Johns Hopkins, Harvard, and NIH.
Validation Evidence
The first longitudinal dataset built from repeatable, self-administered testing across all five senses, establishing a new reference standard for early functional decline.
Population patterns
Consistent with Large-Scale Population Studies
Mortality risk rises with severity of sensory changes.Hearing and vision impairments show clear dose-dependent hazard ratios.
Functional decline modeled with and without early sensory intervention.Tracking senses defines the window where slope can still be changed.
Measured prevalence of reduced sensory function in our cohort matches rates reported in large-scale studies (NIH, JAMA, Lancet).
Expected age-related decline contrasted with trajectories shaped by cumulative life events.
This moves large-scale patterns into a personal, trackable framework.
Individual Sensory Tests
Distribution of function across each sense in our cohort.
Variability is measurable and consistent with population biology
Scientific Leadership
Sita Kedia, MD, MPH, IFMCP
Preventive Neurology & Brain Health
Dr. Kedia is a triple board-certified neurologist and brain health specialist focused on early, preventive approaches to cognitive change. She works at the intersection of clinical neurology and lifestyle medicine, helping people translate complex neuroscience into everyday decisions.
"Early changes in smell and hearing are often the brain’s first quiet signals that something is shifting. We should be tracking those senses as routinely as blood pressure or cholesterol—and tools like SuperSenses finally make that kind of at-home tracking realistic, so we can pay attention to changes long before more obvious symptoms appear.”
Reza Hosseini Ghomi, MD, MSE
Neuropsychiatry & Brain Health
Dr. Ghomi is a neuropsychiatrist with an engineering background focused on brain health and cognitive aging. His work bridges clinical neuroscience and digital health, with an emphasis on turning early, repeatable signals into practical monitoring and decision support over time.Quote:
"Earlier measurement improves the quality of downstream decisions."
Vince Bennett, MD, FAAEM
Dr. Vince Bennett is a physician focused on longevity medicine and early intervention. His commitment to preventive healthcare aligns with the SuperSenses approach.
Dr. Jon Overdevest, MD PhD
Otolaryngology & Sensory Neuroscience
Dr. Overdevest directs the Smell and Taste Center at Columbia University and is a dual-trained physician-scientist in otolaryngology and sensory neuroscience.
Dr. Yangyang Deng, PhD
Biostatistics & Longitudinal Health Modeling
Dr. Deng is a faculty biostatistician at Johns Hopkins University with deep expertise in longitudinal health modeling, wearable sensor data, and early disease detection.
Andrea Tales, PhD, FBPsS, FLSW
Neuropsychology & Dementia Research
Professor Tales holds a Personal Chair in Neuropsychology & Dementia Research at Swansea University, where she leads work on cognitive aging, attention, and everyday sensory/perceptual change in dementia.
"We’ve underestimated everyday sensory/perceptual change in dementia; aligning rigorous science with practical, scalable tools is the next step.”
Mariano Mastinu, PhD
Gustatory Assessment & Chemosensation
Dr. Mastinu is a researcher at the Smell & Taste Clinic, Department of Otolaryngology, Universitätsklinikum Carl Gustav Carus, TU Dresden. His work spans gustatory and trigeminal function and clinical strip-based taste assessment.
David Knight, BSc(Hons), MCOptom, DipTp(IP)
Clinical Research Optometry
David Knight is an Advanced Clinical Research Optometrist at the Royal Victoria Infirmary in Newcastle, where he delivers ophthalmic research and works across medical retina, cataract, low vision, and paediatric clinics. An independent-prescribing optometrist with a professional certificate in medical retina, he also holds a second honours degree in computing and software engineering.
Carl Philpott, MD, FRCS(ORL-HNS)
Rhinology & Olfactology
Professor Philpott holds the Chair of Rhinology & Olfactology at the University of East Anglia and is a Consultant ENT Surgeon, one of the UK's leading authorities on smell and taste. He founded Fifth Sense, the charity for people affected by smell and taste disorders, and directs the UK Smell & Taste Clinics.
